GBS Inc. (NYSE:GBS – Get Free Report) shares dropped 1% on Friday . The stock traded as low as $1.89 and last traded at $2.00. Approximately 702,094 shares changed hands during mid-day trading, a decline of 27% from the average daily volume of 955,325 shares. The stock had previously closed at $2.02.
GBS Stock Down 1.0 %
The stock has a market capitalization of $29.78 million, a P/E ratio of -3.57 and a beta of 1.32. The firm’s 50 day simple moving average is $1.43 and its two-hundred day simple moving average is $2.48.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
See Also
- Five stocks we like better than GBS
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- What is the Nikkei 225 index?
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- How to Invest in Small Cap Stocks
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
